With Mpox Vaccine In Serum Institute Pipeline, What Could Favor India Vaccine Makers?

 
• By Vibha Ravi

Serum Institute is working on an mpox vaccine while other Indian firms are weighing options after the WHO sounded an alert and a new case was reported in neighboring Pakistan. Scrip looks at factors that could favor development and/or manufacture of an mpox vaccine at Indian majors.

Stepping Up To Bat
Can Indian Firms Step Up To The Plate With An Mpox Vaccine? • Source: Shutterstock

More from India

More from Focus On Asia